140 related articles for article (PubMed ID: 22323582)
1. Microchimerism in cord blood: mother as anticancer drug.
Burlingham WJ; Nelson JL
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2190-1. PubMed ID: 22323582
[No Abstract] [Full Text] [Related]
2. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.
van Rood JJ; Stevens CE; Smits J; Carrier C; Carpenter C; Scaradavou A
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19952-7. PubMed ID: 19901324
[TBL] [Abstract][Full Text] [Related]
3. Microchimerism and allogeneic transplantation: we need the proof in the pudding.
van Besien K; Liu HT; Artz A
Chimerism; 2013; 4(3):109-10. PubMed ID: 23511912
[No Abstract] [Full Text] [Related]
4. HLA-mismatched, noninherited maternal antigen-matched unrelated cord blood transplantations have superior survival: how HLA typing the cord blood donor's mother can move the field forward.
Scaradavou A
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1773-5. PubMed ID: 23078783
[No Abstract] [Full Text] [Related]
5. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
6. Unrelated-donor cord blood transplantation for adult hematological malignancies.
Moscardó F; Sanz GF; Sanz MA
Leuk Lymphoma; 2004 Jan; 45(1):11-8. PubMed ID: 15061192
[TBL] [Abstract][Full Text] [Related]
7. HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.
Stevens CE; Carrier C; Carpenter C; Sung D; Scaradavou A
Blood; 2011 Oct; 118(14):3969-78. PubMed ID: 21750317
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis.
Ruggeri A; Rocha V; Masson E; Labopin M; Cunha R; Absi L; Boudifa A; Coeffic B; Devys A; De Matteis M; Dubois V; Hanau D; Hau F; Jollet I; Masson D; Pedron B; Perrier P; Picard C; Ramouneau-Pigot A; Volt F; Charron D; Gluckman E; Loiseau P
Haematologica; 2013 Jul; 98(7):1154-60. PubMed ID: 23242594
[TBL] [Abstract][Full Text] [Related]
9. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.
Cutler C; Kim HT; Sun L; Sese D; Glotzbecker B; Armand P; Koreth J; Ho V; Alyea E; Ballen K; Ritz J; Soiffer RJ; Milford E; Antin JH
Blood; 2011 Dec; 118(25):6691-7. PubMed ID: 21940825
[TBL] [Abstract][Full Text] [Related]
10. Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.
Laughlin MJ; Rizzieri DA; Smith CA; Moore JO; Lilly S; McGaughey D; Martin P; Carrier C; Stevens CE; Rubinstein P; Buckley R; Kurtzberg J
Leuk Res; 1998 Mar; 22(3):215-9. PubMed ID: 9619913
[No Abstract] [Full Text] [Related]
11. The impact of HLA antibodies on engraftment of unrelated cord blood transplants.
Takanashi M; Fujiwara K; Tanaka H; Satake M; Nakajima K
Transfusion; 2008 Apr; 48(4):791-3. PubMed ID: 18366463
[No Abstract] [Full Text] [Related]
12. [Allogeneic cord blood transplantation for adults: current results and future development].
Labussiere H; Peffault de Latour R; Bay JO
Bull Cancer; 2010 Jan; 97(1):137-48. PubMed ID: 20018584
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetic factors in the selection of cord blood units for transplantation: current search strategies and future perspectives.
Geneugelijk K; Spierings E
Cytotherapy; 2015 Jun; 17(6):702-710. PubMed ID: 25770679
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host-disease after double cord blood transplantation: a new look at its characteristics.
Milano F; Delaney C; Storb R
Biol Blood Marrow Transplant; 2013 Jun; 19(6):847-8. PubMed ID: 23583824
[No Abstract] [Full Text] [Related]
15. Allele-level HLA cord blood matching matters.
Oran B; Shpall EJ
Blood; 2014 Jan; 123(1):8-9. PubMed ID: 24385496
[No Abstract] [Full Text] [Related]
16. [Treatment of two case childhood acute lymphoblastic leukemia by HLA-mismatched unrelated umbilical cord blood transplantation].
Sun Z; Wang Z; Zhu W; Liu H; Liu X; Liu Z; Wang N; Pan L; Wu S; Wu J
Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):198-201. PubMed ID: 12133457
[TBL] [Abstract][Full Text] [Related]
17. Low usage rate of banked sibling cord blood units in hematopoietic stem cell transplantation for children with hematological malignancies: implications for directed cord blood banking policies.
Goussetis E; Peristeri I; Kitra V; Papassavas AC; Theodosaki M; Petrakou E; Spiropoulos A; Paisiou A; Soldatou A; Stavropoulos-Giokas C; Graphakos S
Blood Cells Mol Dis; 2011 Feb; 46(2):177-81. PubMed ID: 21095146
[TBL] [Abstract][Full Text] [Related]
18. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
[TBL] [Abstract][Full Text] [Related]
19. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.
Rocha V; Spellman S; Zhang MJ; Ruggeri A; Purtill D; Brady C; Baxter-Lowe LA; Baudoux E; Bergamaschi P; Chow R; Freed B; Koegler G; Kurtzberg J; Larghero J; Lecchi L; Nagler A; Navarrette C; Prasad V; Pouthier F; Price T; Ratanatharathorn V; van Rood JJ; Horowitz MM; Gluckman E; Eapen M;
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1890-6. PubMed ID: 22814031
[TBL] [Abstract][Full Text] [Related]
20. Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation.
Cunha R; Zago MA; Querol S; Volt F; Ruggeri A; Sanz G; Pouthier F; Kogler G; Vicario JL; Bergamaschi P; Saccardi R; Lamas CH; Díaz-de-Heredia C; Michel G; Bittencourt H; Tavella M; Panepucci RA; Fernandes F; Pavan J; Gluckman E; Rocha V;
Blood; 2017 Jan; 129(4):525-532. PubMed ID: 27811020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
